rs6739001
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_000079.4(CHRNA1):c.1073A>T(p.Asp358Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00339 in 1,614,218 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000079.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 1AInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- myasthenic syndrome, congenital, 1B, fast-channelInheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNA1 | NM_000079.4 | c.1073A>T | p.Asp358Val | missense_variant | Exon 8 of 9 | ENST00000348749.9 | NP_000070.1 | |
| CHRNA1 | NM_001039523.3 | c.1148A>T | p.Asp383Val | missense_variant | Exon 9 of 10 | NP_001034612.1 | ||
| CHRNA1 | XM_017003256.2 | c.1169A>T | p.Asp390Val | missense_variant | Exon 8 of 9 | XP_016858745.1 | ||
| CHRNA1 | XM_017003257.2 | c.1094A>T | p.Asp365Val | missense_variant | Exon 7 of 8 | XP_016858746.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0189 AC: 2879AN: 152212Hom.: 86 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00473 AC: 1188AN: 251410 AF XY: 0.00363 show subpopulations
GnomAD4 exome AF: 0.00178 AC: 2597AN: 1461888Hom.: 72 Cov.: 33 AF XY: 0.00154 AC XY: 1122AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0189 AC: 2883AN: 152330Hom.: 86 Cov.: 33 AF XY: 0.0188 AC XY: 1397AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:4
Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
Lethal multiple pterygium syndrome Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
- -
not provided Benign:1
- -
Congenital myasthenic syndrome Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at